Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. Selpercatinib

   Eli Lilly and Company

   Non-Small Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

2. Sevabertinib

   Bayer HealthCare AG

   Advanced Non-small Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

3. Sigvotatug Vedotin

   Pfizer

   Non-Small Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

4. Somatostatin

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Gallbladder Neoplasms

   phase 3 · small molecule · completed

   1 trial →

5. Sonrotoclax

   BEONE MEDICINES AUS PTY LTD

   Mantle Cell Lymphoma

   phase 3 · small molecule · active

   1 trial →

6. Sonrotoclax

   BEONE MEDICINES AUS PTY LTD

   Chronic Lymphocytic Leukemia

   phase 3 · small molecule · active

   4 trials →

7. Soquelitinib

   Corvus Pharmaceuticals

   Peripheral T-Cell Lymphoma, Not Otherwise Specified

   phase 3 · small molecule · active

   1 trial →

8. Sorafenib

   The First People's Hospital of Lianyungang

   Acute Myeloid Leukemia

   phase 3 · small molecule · completed

   1 trial →

9. Sorafenib

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Hepatocellular Carcinoma

   phase 3 · small molecule · active

   2 trials →

10. Sorafenib (Nexavar, BAY43-9006)

    Bayer HealthCare AG

    Carcinoma, Hepatocellular

    phase 3 · small molecule · completed

    1 trial →

11. Sorafenib (Nexavar, BAY43-9006)

    Bayer HealthCare AG

    Carcinoma

    phase 3 · small molecule · completed

    1 trial →

12. Standard First-Line Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unresectable Colorectal Cancer

    phase 3 · small molecule · active

    1 trial →

13. Standard of Care

    Telix Innovations

    Metastatic Prostate Cancer

    phase 3 · small molecule · terminated

    1 trial →

14. Standard of Care

    AbbVie

    Non-Squamous Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

15. Standard treatment: Control arm

    United Therapeutics Europe Ltd

    Cervical Carcinoma

    phase 3 · other · active

    1 trial →

16. Subcutaneous Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Metastatic Gastric Adenocarcinoma

    phase 3 · small molecule · active

    1 trial →

17. Subxiphoid uniportal VATS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mediastinal Neoplasms

    phase 3 · other · active

    1 trial →

18. Subxiphoid uniportal VATS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Neoplasms

    phase 3 · other · completed

    1 trial →

19. Suprefact Depot 9 for low-volume metastatic castration-sensitive prostate cancer

    Disc Medicine

    low-volume metastatic castration-sensitive prostate cancer

    phase 3 · small molecule · active

    1 trial →

20. Surgery and HIPEC with Lobaplatin

    Universal Integrated

    Colorectal Neoplasms

    phase 3 · other · active

    1 trial →

21. Surovatamig

    AstraZeneca

    Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV

    phase 3 · small molecule · active

    1 trial →

22. Systematic oral health education

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor of Head and/or Neck

    phase 3 · other · completed

    1 trial →

23. TAK-788

    Takeda

    Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

24. TAMOXIFEN for Breast cancer

    Shanghai Reinovax Biologics Co.,LTD

    Breast cancer

    phase 3 · small molecule · active

    1 trial →

25. TAP-144-SR(6M)

    Takeda

    Prostate Cancer

    phase 3 · small molecule · completed

    1 trial →

26. TAP-144-SR(6M)

    Takeda

    Premenopausal Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

27. TARA-002

    Protara Therapeutics

    Bladder (Urothelial, Transitional Cell) Cancer

    phase 3 · small molecule · active

    1 trial →

28. TAS6417-301

    Taiho Pharma Netherlands B.V.

    Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

    phase 3 · small molecule · active

    1 trial →

29. TAXOL for Recurrent or Metastatic HER2 Ne…

    Lacuna Pharma Pty Ltd

    Recurrent or Metastatic HER2 Negative Breast Cancer

    phase 3 · small molecule · active

    1 trial →

30. TCM

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

31. THIO-104

    MAIA Biotechnology

    Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

32. TPST-1120

    Tempest Therapeutics

    Hepatocellular Carcinoma (HCC)

    phase 3 · small molecule · active

    1 trial →

33. TRIO041

    Wuhan Createrna Science and Technology Co., Ltd

    Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria.

    phase 3 · small molecule · active

    1 trial →

34. Tamoxifen

    Pfizer

    Breast Neoplasms

    phase 3 · small molecule · completed

    1 trial →

35. Tamoxifen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer Female

    phase 3 · small molecule · active

    1 trial →

36. Tamoxifen

    International Peace Maternity and Child Health Hospital

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

37. Tamoxifen Viatris 20 mg tabletter.

    The George Institute

    Breast Cancer

    phase 3 · small molecule · active

    1 trial →

38. Tarlatamab

    Amgen

    Extensive-Stage Small-Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

39. Tarlatamab

    Amgen

    Small Cell Lung Cancer (SCLC)

    phase 3 · small molecule · active

    1 trial →

40. Taselisib

    Hoffmann-La Roche

    Breast Cancer

    phase 3 · small molecule · terminated

    1 trial →

41. Tasisulam-sodium

    Eli Lilly and Company

    Melanoma

    phase 3 · small molecule · terminated

    1 trial →

42. Taxane

    Hoffmann-La Roche

    Gastric Cancer

    phase 3 · small molecule · terminated

    1 trial →

43. Taxotere , Epirubicin

    Hospital Authority, Hong Kong

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

44. Tecentriq 1 200 mg concentrate for solution for infusion

    Ningbo Cancer Hospital

    High-risk non-muscle invasive bladder cancer (NMIBC) after transurethral resection of the bladder (TURBT) and pathological assessment.

    phase 3 · small molecule · active

    1 trial →

45. Tecentriq 1 200 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Cancer (Future parent protocols may include other cancer that are not included in this section)

    phase 3 · small molecule · active

    1 trial →

46. Tecentriq 840 mg concentrate for solution for infusion

    Novo Nordisk A/S

    Metastatic pancreatic ductal adenocarcinoma (mPDAC)

    phase 3 · small molecule · active

    1 trial →

47. Tegafur-Gimeracil-Oteracil Potassium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stomach Neoplasm

    phase 3 · small molecule · completed

    1 trial →

48. Telisotuzumab Adizutecan

    AbbVie

    Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions